肥胖研究——方法、测量及药物的局限性 - Suppr

Suppr

超能文献

Obesity research--limitations of methods, measurements, and medications.

作者信息

Simons-Morton Denise G, Obarzanek Eva, Cutler Jeffrey A

出版信息

JAMA. 2006 Feb 15;295(7):826-8. doi: 10.1001/jama.295.7.826.

DOI:10.1001/jama.295.7.826

PMID:16478906

Abstract

摘要

相似文献

Obesity research--limitations of methods, measurements, and medications.

JAMA. 2006 Feb 15;295(7):826-8. doi: 10.1001/jama.295.7.826.

[Pharmacotherapy of obesity].

Ugeskr Laeger. 2004 Oct 18;166(43):3814-7.

[New drugs for the treatment of obesity].

Duodecim. 1999;115(20):2191, 2193-4.

Pharmacological treatment of obesity in children and adolescents: current status and perspectives.

Expert Opin Pharmacother. 2010 Dec;11(18):2973-83. doi: 10.1517/14656566.2010.512005. Epub 2010 Oct 19.

European Society of Hypertension Working Group on Obesity: obesity drugs and cardiovascular outcomes.

J Hypertens. 2011 Feb;29(2):189-93. doi: 10.1097/HJH.0b013e3283427c8b.

Medications for weight reduction.

Med Clin North Am. 2011 Sep;95(5):989-1008. doi: 10.1016/j.mcna.2011.06.009.

Clinical trial design for obesity agents: a workshop report.

Obes Res. 1998 Jul;6(4):311-5. doi: 10.1002/j.1550-8528.1998.tb00355.x.

Medical therapy for obesity--current status and future hopes.

Med Clin North Am. 2007 Nov;91(6):1225-53, xi. doi: 10.1016/j.mcna.2007.06.013.

Pharmaceutical treatment of obesity.

Nurs Clin North Am. 1997 Dec;32(4):831-48.

Rimonabant, obesity and diabetes.

Prescrire Int. 2007 Jun;16(89):122.

引用本文的文献

Low-carbohydrate versus balanced-carbohydrate diets for reducing weight and cardiovascular risk.

Cochrane Database Syst Rev. 2022 Jan 28;1(1):CD013334. doi: 10.1002/14651858.CD013334.pub2.

Perception of body size and body dissatisfaction in adults.

Sci Rep. 2022 Jan 27;12(1):1159. doi: 10.1038/s41598-021-04706-6.

The limits and challenges of antiobesity pharmacotherapy.

Expert Opin Pharmacother. 2020 Aug;21(11):1319-1328. doi: 10.1080/14656566.2020.1748599. Epub 2020 Apr 15.

The Effects of Reverse Causality and Selective Attrition on the Relationship Between Body Mass Index and Mortality in Postmenopausal Women.

Am J Epidemiol. 2019 Oct 1;188(10):1838-1848. doi: 10.1093/aje/kwz160.

Maximizing retention in long-term clinical trials of a weight loss agent: use of a dietitian support team.

Obes Sci Pract. 2016 Sep;2(3):256-265. doi: 10.1002/osp4.57. Epub 2016 Aug 2.

Weight-Loss Diets, Adiponectin, and Changes in Cardiometabolic Risk in the 2-Year POUNDS Lost Trial.

J Clin Endocrinol Metab. 2016 Jun;101(6):2415-22. doi: 10.1210/jc.2016-1207. Epub 2016 Apr 7.

Obesity: Liraglutide--another weapon in the war against obesity?

Nat Rev Endocrinol. 2015 Oct;11(10):569-70. doi: 10.1038/nrendo.2015.133. Epub 2015 Aug 11.

Comparison of results from different imputation techniques for missing data from an anti-obesity drug trial.

PLoS One. 2014 Nov 19;9(11):e111964. doi: 10.1371/journal.pone.0111964. eCollection 2014.

Low carbohydrate versus isoenergetic balanced diets for reducing weight and cardiovascular risk: a systematic review and meta-analysis.

PLoS One. 2014 Jul 9;9(7):e100652. doi: 10.1371/journal.pone.0100652. eCollection 2014.

Long-term drug treatment for obesity: a systematic and clinical review.

JAMA. 2014 Jan 1;311(1):74-86. doi: 10.1001/jama.2013.281361.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Obesity research--limitations of methods, measurements, and medications.

JAMA. 2006 Feb 15;295(7):826-8. doi: 10.1001/jama.295.7.826.

[Pharmacotherapy of obesity].

Ugeskr Laeger. 2004 Oct 18;166(43):3814-7.

[New drugs for the treatment of obesity].

Duodecim. 1999;115(20):2191, 2193-4.

Pharmacological treatment of obesity in children and adolescents: current status and perspectives.

Expert Opin Pharmacother. 2010 Dec;11(18):2973-83. doi: 10.1517/14656566.2010.512005. Epub 2010 Oct 19.

European Society of Hypertension Working Group on Obesity: obesity drugs and cardiovascular outcomes.

J Hypertens. 2011 Feb;29(2):189-93. doi: 10.1097/HJH.0b013e3283427c8b.

Medications for weight reduction.

Med Clin North Am. 2011 Sep;95(5):989-1008. doi: 10.1016/j.mcna.2011.06.009.

Clinical trial design for obesity agents: a workshop report.

Obes Res. 1998 Jul;6(4):311-5. doi: 10.1002/j.1550-8528.1998.tb00355.x.

Medical therapy for obesity--current status and future hopes.

Med Clin North Am. 2007 Nov;91(6):1225-53, xi. doi: 10.1016/j.mcna.2007.06.013.

Pharmaceutical treatment of obesity.

Nurs Clin North Am. 1997 Dec;32(4):831-48.

Rimonabant, obesity and diabetes.

Prescrire Int. 2007 Jun;16(89):122.

引用本文的文献

Low-carbohydrate versus balanced-carbohydrate diets for reducing weight and cardiovascular risk.

Cochrane Database Syst Rev. 2022 Jan 28;1(1):CD013334. doi: 10.1002/14651858.CD013334.pub2.

Perception of body size and body dissatisfaction in adults.

Sci Rep. 2022 Jan 27;12(1):1159. doi: 10.1038/s41598-021-04706-6.

The limits and challenges of antiobesity pharmacotherapy.

Expert Opin Pharmacother. 2020 Aug;21(11):1319-1328. doi: 10.1080/14656566.2020.1748599. Epub 2020 Apr 15.

The Effects of Reverse Causality and Selective Attrition on the Relationship Between Body Mass Index and Mortality in Postmenopausal Women.

Am J Epidemiol. 2019 Oct 1;188(10):1838-1848. doi: 10.1093/aje/kwz160.

Maximizing retention in long-term clinical trials of a weight loss agent: use of a dietitian support team.

Obes Sci Pract. 2016 Sep;2(3):256-265. doi: 10.1002/osp4.57. Epub 2016 Aug 2.

Weight-Loss Diets, Adiponectin, and Changes in Cardiometabolic Risk in the 2-Year POUNDS Lost Trial.

J Clin Endocrinol Metab. 2016 Jun;101(6):2415-22. doi: 10.1210/jc.2016-1207. Epub 2016 Apr 7.

Obesity: Liraglutide--another weapon in the war against obesity?

Nat Rev Endocrinol. 2015 Oct;11(10):569-70. doi: 10.1038/nrendo.2015.133. Epub 2015 Aug 11.

Comparison of results from different imputation techniques for missing data from an anti-obesity drug trial.

PLoS One. 2014 Nov 19;9(11):e111964. doi: 10.1371/journal.pone.0111964. eCollection 2014.

Low carbohydrate versus isoenergetic balanced diets for reducing weight and cardiovascular risk: a systematic review and meta-analysis.

PLoS One. 2014 Jul 9;9(7):e100652. doi: 10.1371/journal.pone.0100652. eCollection 2014.

Long-term drug treatment for obesity: a systematic and clinical review.

JAMA. 2014 Jan 1;311(1):74-86. doi: 10.1001/jama.2013.281361.